BAC:NYSEBank of America Corporation Analysis
Data as of 2026-03-09 - not real-time
$47.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Bank of America (BAC) is trading at $47.00, near its 20‑day support of $46.78 and well below the 52‑week high of $57.55. The Relative Strength Index sits at 28, signaling an oversold condition, while the MACD remains bearish, suggesting short‑term momentum is still negative. Fundamentally, the stock trades at a forward P/E of 9.5 versus an industry average of 17.1, indicating a valuation discount, and it offers a 2.3% dividend yield with a modest 28% payout ratio, supporting dividend sustainability. The DCF‑derived fair value of roughly $23 is far below the market price, but the calculated upside/downside metric of +32.6% and hedge‑fund sentiment describing BAC as a “highly favored long‑term buy” point to perceived upside potential.
The balance sheet shows roughly equal cash and debt levels, a neutral beta (~1.0) and a 30% 30‑day volatility, implying market‑wide risk but not excessive company‑specific risk. Overall, the mix of technical oversold signals, attractive valuation multiples, solid dividend yield, and positive analyst consensus suggests a buying opportunity, especially for investors comfortable with medium‑term volatility.
The balance sheet shows roughly equal cash and debt levels, a neutral beta (~1.0) and a 30% 30‑day volatility, implying market‑wide risk but not excessive company‑specific risk. Overall, the mix of technical oversold signals, attractive valuation multiples, solid dividend yield, and positive analyst consensus suggests a buying opportunity, especially for investors comfortable with medium‑term volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Price near strong support level
- Attractive dividend yield with low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E well below industry average
- Positive hedge‑fund sentiment and analyst consensus
- Sustainable dividend and improving earnings outlook
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable dividend policy and solid ROE
- Exposure to interest‑rate environment and regulatory landscape
- Valuation discount provides margin of safety
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin28.40%
P/E Ratio12.3
ROE10.22%
ROA0.91%
P/B Ratio1.2
Op. Cash Flow$12.6B
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI28.4
Support$46.78
Resistance$56.83
MA 20$51.67
MA 50$53.26
MA 200$50.52
MACDBearish
VolumeIncreasing
Fear & Greed Index100
Valuation
Fair Value$23.25
Target Price$62.35
Upside/Downside32.65%
GradeUndervalued
TypeBlend
Dividend Yield2.30%
Risk Assessment
Beta0.98
Volatility30.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.